S&P 500 Futures
(-0.10%) 5 302.75 points
Dow J Futures
(-0.03%) 40 130 points
Nasdaq Futures
(-0.18%) 18 471 points
Oil
(0.63%) $81.86
Gas
(-1.40%) $1.694
Gold
(0.16%) $2 216.30
Silver
(-0.77%) $24.56
Platinum
(-0.15%) $908.30
USD/EUR
(0.49%) $0.928
USD/NOK
(0.78%) $10.85
USD/GBP
(0.36%) $0.794
USD/RUB
(-0.15%) $92.30

Realtime updates for Oncosil Medical Ltd [OSL.AX]

Exchange: ASX Industry: Pharmaceuticals, Biotechnology & Life Sciences
Last Updated27 Mar 2024 @ 19:06

0.00% $ 0.00500

Live Chart Being Loaded With Signals

Commentary (27 Mar 2024 @ 19:06):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide...

Stats
Today's Volume 660 000
Average Volume 1.93M
Market Cap 11.85M
EPS $0 ( 2024-02-25 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.500
ATR14 $0 (0.00%)

Oncosil Medical Ltd Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Oncosil Medical Ltd Financials

Annual 2023
Revenue: $367 677
Gross Profit: $-6.49M (-1 766.30 %)
EPS: $-0.0100
Q2 2023
Revenue: $87 956.00
Gross Profit: $-3.22M (-3 665.66 %)
EPS: $-0.00300
Q4 2023
Revenue: $151 352
Gross Profit: $-3.43M (-2 266.03 %)
EPS: $-0.00430
Q3 2022
Revenue: $328 917
Gross Profit: $-186 673 (-56.75 %)
EPS: $-0.00220

Financial Reports:

No articles found.

Oncosil Medical Ltd

OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced unresectable pancreatic cancer, in combination with gemcitabine-based chemotherapy. The company was formerly known as NeuroDiscovery Limited and changed its name to OncoSil Medical Limited in May 2013. OncoSil Medical Limited was incorporated in 2005 and is headquartered in North Sydney, Australia.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators